James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 40,000 shares at $2.08 ($83K) on 2021-04-22, disclosed to the SEC on 2021-04-27.
Open-market purchase of $83k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.08 | 4,100 | $9K | 10.2% |
| 2 | $2.08 | 6,000 | $12K | 15.0% |
| 3 | $2.08 | 900 | $2K | 2.2% |
| 4 | $2.09 | 2,000 | $4K | 5.0% |
| 5 | $2.05 | 5,000 | $10K | 12.3% |
| 6 | $2.07 | 7,000 |
| $14K |
| 17.4% |
| 7 | $2.08 | 51 | $106 | 0.1% |
| 8 | $2.09 | 200 | $418 | 0.5% |
| 9 | $2.09 | 1,100 | $2K | 2.8% |
| 10 | $2.09 | 2,900 | $6K | 7.3% |
| 11 | $2.09 | 4,949 | $10K | 12.4% |
| 12 | $2.10 | 800 | $2K | 2.0% |
| 13 | $2.11 | 3,100 | $7K | 7.9% |
| 14 | $2.13 | 1,900 | $4K | 4.9% |
| Total | $2.08 avg | 40,000 | $83K | 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |
| NYMX | BUY | 2019-07-10 | $11K | — | Filing → |